Skip to main content
. 2021 May 25;6(22):14430–14441. doi: 10.1021/acsomega.1c01314

Figure 1.

Figure 1

(A) PCA-based three-dimensional and (B) two-dimensional property space scatter plot of FDA-approved drugs (green spheres), DprE1 inhibitors (red spheres), and anti-TB drugs (blue spheres) based on 10 2D descriptors.